TrimRx vs Henry Meds: Comparing Compounded GLP-1 Providers

Henry Meds and TrimRx are both telehealth platforms offering compounded GLP-1 medications, and on the surface they look similar. Both skip the in-person visit. Both ship medication to your door. Both operate without requiring insurance. But the differences between them are worth understanding before you decide where to get your care.

Where Each Platform Comes From

Henry Meds launched as a hormone optimization platform, initially focused on testosterone replacement therapy and hormone health for men. It expanded into weight loss as GLP-1 medications grew in demand, adding compounded semaglutide to its offerings as part of a broader men’s health and wellness service. Like several platforms that have added GLP-1s to an existing product line, its weight loss offering exists within a wider health ecosystem.

TrimRx was built specifically around GLP-1 weight loss from the beginning. The platform doesn’t offer hormone replacement therapy, general wellness programs, or other health services alongside its weight loss offering. It exists to provide medically supervised GLP-1 treatment, and that singular focus shapes the clinical depth behind every part of the service.

That origin story matters because it reflects the priorities baked into each platform’s design. A platform built around hormone optimization that adds GLP-1s is optimized for hormone therapy first. A platform built around GLP-1 weight loss is optimized for exactly that.

Medication Range and Treatment Flexibility

This is one of the most practically significant differences between these two platforms. TrimRx offers compounded semaglutide, compounded tirzepatide, and brand-name GLP-1 medications including Ozempic, Wegovy, Mounjaro, and Zepbound. That full range gives providers the ability to tailor treatment to individual patients and adjust as needs change over time.

Henry Meds has primarily offered compounded semaglutide as its weight loss medication. For patients who start treatment and later want to explore tirzepatide, or whose provider determines that a brand-name medication is more appropriate, a platform with a narrower medication menu creates a limitation that requires switching services to resolve.

The clinical significance of having both semaglutide and tirzepatide available within a single platform is real. Research published in the New England Journal of Medicine demonstrated that tirzepatide produced significantly greater average weight loss than semaglutide in patients with obesity, which means the right medication isn’t the same for every patient. Providers who can prescribe both have more tools to work with, and patients don’t have to restart their care somewhere else if their treatment needs to evolve.

For patients who want to understand the clinical differences between these two medications before choosing, the article on how to choose between Ozempic and Mounjaro covers the key considerations in plain language.

Clinical Oversight and Provider Expertise

Both platforms use a telehealth model in which a licensed provider reviews your health intake and issues a prescription if appropriate. The quality of that oversight depends on the depth of clinical experience behind it and how well the protocols are designed for GLP-1 specifically.

TrimRx’s providers work exclusively in GLP-1 weight loss, which means dose escalation decisions, progress monitoring, and treatment adjustments are handled by clinicians whose daily practice is centered on exactly this type of care. The intake process is designed to capture the specific health factors that matter for GLP-1 prescribing, and the follow-up structure is built around tracking weight loss outcomes rather than general wellness metrics.

For patients who want to understand what good clinical oversight of GLP-1 treatment looks like in practice, including what lab work and monitoring to expect, the article on what lab tests to expect while on GLP-1 medications provides a useful reference.

Pricing and Cost Transparency

Both platforms offer compounded semaglutide at prices significantly below brand-name alternatives, which is the primary appeal of compounded options for patients paying out of pocket. TrimRx’s compounded semaglutide starts around $179 per month, with compounded tirzepatide also available at competitive pricing.

When comparing costs between platforms, it’s worth looking beyond the headline price to understand what’s included. Does the price cover provider consultations? Is dose escalation support included? Are there additional fees for follow-up care? These factors affect the true cost of treatment and the quality of the clinical experience you’re paying for.

The Compounded Medication Question

Both platforms use compounded medications prepared by licensed pharmacies. Compounded semaglutide and tirzepatide are not FDA-approved products, but they can be legally prescribed and dispensed under specific regulatory conditions. The quality of the compounding pharmacy behind your medication matters, and it’s worth understanding how to evaluate that before starting any compounded GLP-1 program.

The article on how to verify a compounding pharmacy is safe covers what accreditation, testing practices, and pharmacy credentials to look for, which applies regardless of which platform you’re considering.

Making the Right Choice for Your Situation

Consider this scenario: a patient starts compounded semaglutide through a platform focused primarily on hormone therapy, loses weight for several months, then reaches a plateau. Their provider recommends trying tirzepatide to push through. If the platform doesn’t carry tirzepatide, that patient now has to find a new provider, complete a new intake, and restart their care from scratch. That disruption is entirely avoidable if the original platform had the full medication range available.

The broader point is that weight loss treatment with GLP-1 medications often spans many months or longer, and the needs of a patient six months into treatment are different from their needs at the start. A platform with a wider medication menu, deeper GLP-1 specialization, and flexible treatment options is better positioned to support the full arc of that journey.

TrimRx is built for exactly that. If you want a platform whose entire clinical infrastructure is oriented around GLP-1 weight loss, with access to both semaglutide and tirzepatide and brand-name options when needed, it’s worth finding out whether you’re a candidate.

Start your assessment and a licensed provider will review your information and help you identify the right starting point for your treatment.

This information is for educational purposes and is not medical advice. Consult with a healthcare provider before starting any medication. Individual results may vary.